Beclomethasone Dipropionate

Producers shown on SFDA

(Record date:12/10/2021）

Producers shown on EP

Not showing any

Producer:Tianjin Tianyao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Tianjin Jinyao Group Co., Ltd., is the first API production unit in Tianjin that has all passed the national GMP certification. It is the largest scientific research, production and export base of steroid corticosteroids in Asia. The company mainly produces more than 40 varieties of corticosteroid raw materials, cardiovascular and cerebrovascular raw materials, analgesic raw materials and preparation drugs, of which many products have passed the certification of FDA and European Pharmacopoeia Committee, and become a qualified supplier of Pfizer and other large multinational companies. The company's leading product dexamethasone (corticosteroid drugs) series technology and product quality have reached the international advanced level. Taking advantage of low cost and service advantages, the company has occupied the Asian market of dexamethasone and opened the European and American markets; The company's annual production capacity of corticosteroid APIs has reached more than 200 tons.
Staff size:About 3000 persons

Registered capital:RMB 1 billion 101 million

Producer:Zhejiang Xianju Xianle Pharmaceutical Co., Ltd., founded in November 1995 and located in the South Industrial Zone of Xianju Chengguan, is a professional manufacturer of steroids with self-supporting import and export rights. The plant covers an area of about 30000m2, with total assets of more than 65 million yuan, and technicians account for about 40% of the total number of employees. The company is a key backbone (2112) enterprise in the county and a provincial high-tech enterprise. It is a "contract abiding and trustworthy" unit in Zhejiang Province and a provincial AAA industrial and commercial credit enterprise. The company's main products are: betamethasone series, dexamethasone series, cyproterone series and more than 20 intermediates. In February 2007, the company passed the GMP certification of the State Food and Drug Administration of the people's Republic of China. At present, FDA and COS certification of relevant products of the company is in progress. The company has won wide praise for organizing production and continuously improving EHS system in strict accordance with drug production quality management specifications. The product quality conforms to bp2007, USP30, ep5, CP2005 and other Pharmacopoeia standards at home and abroad. The products are mainly sold to Europe, America, Southeast Asia, the Middle East, India and other countries and regions.

Staff size:100-199 persons

Registered capital:RMB 10 million

Producer:Shanghai New Hualian Pharmaceutical Co., Ltd. is a national high-tech enterprise. Its predecessor is New Hualian pharmaceutical factory of Shanghai Pharmaceutical (Group) Co., Ltd. It has a pharmaceutical history of 80 years since its establishment in 1939. The company is located at No. 217, Minle Road, Xinghuo Development Zone, Fengxian District, Shanghai, covering an area of 341 Mu and a construction area of 67000 square meters. At present, it has 40 drug approvals and 18 GMP workshops. Among them, mifepristone and other products have passed the U.S. FDA, isotretinoin and other products have obtained the CEP certificate issued by European EDQM, and many products have passed certification and registration in many countries and regions. The company has professional R & D and industrialization capabilities of pharmaceutical products, standardized GMP management system, advanced drug testing instruments and production equipment, and a stable professional team.

Staff size:200-299 persons

Registered capital:RMB 107 million 636 thousand and 649

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978